Prevalence and Determinant of RH Alloimmunization in RH Negative Women in three Teaching Hospitals, Addis Ababa, Ethiopia, 2021
No Thumbnail Available
Date
2021-09
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Addis Abeba University
Abstract
Background: Although the risks of adverse pregnancy outcomes associated with anti-D
antibodies are reduced after the implementation of immunization to the D antigen, it’s still a
concern for most Sub-Saharan African countries, where there is poor and sometimes no
Alloimmunization prevention following potentially sensitizing events. This may result in the
compromise of the woman’s obstetric care and increase perinatal morbidity and mortality. In
Ethiopia the weight of the problem is less known and there is no study done in the study area.
This study intended to fill this knowledge gap.
Objective: To study prevalence and determinant of Rh Alloimmunization in Rh negative
mother in three teaching hospitals (TAH, GMH and ZMH) Addis Ababa, Ethiopia.
Methods and Materials: Hospital based cross-sectional study was conducted from 328 Rh
negative pregnant women who booked for antenatal and delivery service utilization in TASH,
GMH and ZMH from October 2020 to May 2021 to assess prevalence and determinant of Rh
Alloimmunization in Rh negative women. The data were collected by means of structured
questionnaires. The data were entered, coded and analyzed using Statistical Package for Social
Science (SPSS) version 25. Descriptive and logistic regression analyses were conducted.
Statistical tests were done at a level of odds ratio with 95% confidence intervals and significance
of p < 0.05. Variables with P value < 0.25 during the bivariate analysis were included in the
multivariate analysis to see the effect of confounding factors
Results and conclusion: The study revealed that prevalence of Rh D negative and Rh
Alloimmunization in the study area were 2.1% and 17.1% respectively. Being unemployed, not
using prophylaxis’s anti-D, having previous sensitizing event and having two or more pregnancy
were statistically significant with Rh alloimmunized (p<0.05).
Recommendation: Improvement of access and affordability of anti-D medication. As a nation
there is no data that assess the determining factor of Rh Alloimmunization so research must be
done with a large sample size to improve the management. In addition assessment of knowledge
and practice of the health professional also important.
Description
Keywords
Rh alloimmunization , Rh negative women